Analyst Price Targets — LMRI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 28, 2026 8:51 am | — | Barclays | $13.00 | $11.73 | TheFly | Lumexa Imaging price target raised to $13 from $9 at Barclays |
| August 13, 2026 1:05 pm | — | Deutsche Bank | $16.00 | $12.35 | TheFly | Lumexa Imaging price target lowered to $16 from $22 at Deutsche Bank |
| May 20, 2026 9:15 am | — | Barclays | $9.00 | $7.00 | TheFly | Lumexa Imaging price target lowered to $9 from $15 at Barclays |
| April 14, 2026 9:40 am | — | Barclays | $15.00 | $9.67 | TheFly | Lumexa Imaging price target lowered to $15 from $23 at Barclays |
| January 5, 2026 12:54 pm | — | Barclays | $23.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Overweight at Barclays |
| January 5, 2026 12:08 pm | — | Deutsche Bank | $22.00 | $17.55 | TheFly | Lumexa Imaging initiated with a Buy at Deutsche Bank |
| January 5, 2026 11:37 am | — | Leerink Partners | $23.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Outperform at Leerink |
| January 5, 2026 11:11 am | — | Raymond James | $23.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Outperform at Raymond James |
| January 5, 2026 10:31 am | — | Wells Fargo | $22.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Overweight at Wells Fargo |
| January 5, 2026 10:13 am | — | H.C. Wainwright | $22.00 | $17.55 | StreetInsider | Wells Fargo Starts Lumexa Imaging Holdings (LMRI) at Overweight |
Latest News for LMRI
BlackRock Inc. bought a new position in shares of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,398,112 shares of the company's stock, valued at approximately $15,771,000. BlackRock Inc. owned approximately 1.46%
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Wells Fargo 21st Annual Healthcare Conference, held in Boston, including a fireside chat at 3:00 PM ET and…
The consensus price target hints at a 36.9% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
Lumexa Imaging NASDAQ: LMRI reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and adjusted earnings-per-share guidance.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LMRI.
U.S. House Trading
No House trades found for LMRI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.